Pr0.7 Ca0.3 Mn1-x Ax O3 (A= Ru, x= 0; 0,05; 0,1; 0,15; 0,2; 0,3; 0,5 ) determination of structural, magnetiv and magnetocaloricproperties of samples
2022
0 görüntülenme
0 i̇ndirme
Danışman: Prof. Dr. Tekin İzgi
Özet (EN)
In this study, the effects of Ru doping on structural, magnetic and magnetocaloric properties of Pr0.7 Ca0.3 Mn1-x Ax O3 (A= Ru, x= 0; 0,05; 0,1; 0,15; 0,2; 0,3; 0,5 ) samples were investigated. It was observed that all the samples had orthorhombic symmetry, although there was no significant change in the X-ray structure analyzes of all the samples doped with Ru instead of Mn. The decrease in Curie temperature and saturation magnetization with Ru content could be due to reduced ferromagnetic effect in Ru -doped compounds. The decrease in magnetic entropy change could be due to the reduction in saturation magnetization with increasing Ru content. It was observed from the drawn arrott graphs that the samples were in binary phase.
Yazar
Dr. Turgut Kanıkırmızı
Bu Yayına Nasıl Atıf Yapılır
Turgut Kanıkırmızı (Master Thesis). Pr0.7 Ca0.3 Mn1-x Ax O3 (A= Ru, x= 0; 0,05; 0,1; 0,15; 0,2; 0,3; 0,5 ) determination of structural, magnetiv and magnetocaloricproperties of samples, 2022, İnönü University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
İnönü University tezlerinden daha fazlası
- Knowledge, opinions and applications of pediatric nurses towards therapeutic games(2017)
- The effects of systemic pistacia eurycarpa yalt administration on alveolar bone loss and oxidative stress in rats with experimental periodontitis(2021)
- The effect of motivational interviews for primiparous pregnant women with low normal birth belief on medical and natural birth belief(2022)
- Retrospective investigation of genetic etiology in pediatric epilepsy patients based on targeted next generation sequence analysis datas(2022)
- The commentary methodology in the commentary on al-Fath al-Mubyn bi-Sharh al-Arba'eyn by Ibn Hajar al-Haytamy(2022)
- Comparison of serum BDNF, S100B levels of patients with bipolar disorder in manic and remission periods with healthy volunteers and evaluation of results with neuropsychological tests(2022)
